Quality of life is an important end point in clinical trials, yet there are few quality of life questionnaires for neuroendocrine tumours. Analysis of QLQ-GINET21 scales confirmed appropriate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback